Polaris Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Polaris Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$96.34 - $112.38 $2.95 Million - $3.44 Million	30,600 Added 5.15%	624,500 $64.2 Million
Q1 2023 Apr 28, 2023	SELL	$107.32 - $113.5 $321,960 - $340,500	-3,000 Reduced 0.5%	593,900 $64.8 Million
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $37.2 Million - $67.9 Million	596,900 New	596,900 $67.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Polaris Capital Management, LLC with notifications on news.